Close

NYSE MKT to Suspend Trading of Provectus Biopharma (PVCT) Shares; Will Move to Delist

Go back to NYSE MKT to Suspend Trading of Provectus Biopharma (PVCT) Shares; Will Move to Delist

Provectus Biopharmaceuticals Announces Poster Presentation on PV-10 at European Society of Medical Oncology 2016 Congress Now Available Online

October 11, 2016 6:01 AM EDT

Poster Updates Details of Studies of PV-10 as Single Agent Therapy and in Combination for Melanoma

KNOXVILLE, Tenn.--(BUSINESS WIRE)-- Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or the "Company), today announced that the poster presented at the European Society of Medical Oncology 2016 Congress is now available online.

Titled... More